Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Williams

Showing results (311-320 of 331) with videos related to

Pageof 34
Sort By:
Oncotarget|April 19, 2014
TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunitiesZenobia C D'Costa, Catherine Higgins, Chee Wee Ong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2024
CB307: A Dual Targeting Costimulatory Humabody VH Therapeutic for Treating PSMA-Positive TumorsSophie Archer, Phillip M Brailey, Minjung Song, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2012
Optimization of an ether series of mGlu5 positive allosteric modulators: molecular determinants of MPEP-site interaction crossoverJason T Manka, Paige N Vinson, Karen J Gregory, et al.
Frontiers in Psychiatry|July 17, 2020
An Open Label Pilot Study of a Brief Psychosocial Intervention for Disaster and Trauma SurvivorsMeaghan Louise O'Donnell, Winnie Lau, Julia Fredrickson, et al.
Molecular Pharmacology|October 7, 2010
Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activityAlice L Rodriguez, Mark D Grier, Carrie K Jones, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 7, 2020
Transoral laser microsurgery and radiotherapy for oropharyngeal squamous cell carcinoma: Equitable survival and enhanced function compared with contemporary standards of careC Lucy Dalton, Kristijonas Milinis, David Houghton, et al.
Oncotarget|April 4, 2012
Stratification of Wilms tumor by genetic and epigenetic analysisRichard H Scott, Anne Murray, Linda Baskcomb, et al.
Nature Communications|February 7, 2026
Pan-RAF inhibitor exarafenib targets BRAF class II/III NSCLC and reveals ARAF-KSR1 resistance and combination strategiesTadashi Manabe, Hannah C Bergo, Qingtian Li, et al.
Plos One|December 20, 2012
Characterisation and validation of insertions and deletions in 173 patient exomesFrancesco Lescai, Silvia Bonfiglio, Chiara Bacchelli, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase InhibitorKevin W Gillman, John E Starrett, Michael F Parker, et al.
Pageof 34

Showing results (311-320 of 331) with videos related to

Sort By:
Pageof 34
Oncotarget|April 19, 2014
TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunitiesZenobia C D'Costa, Catherine Higgins, Chee Wee Ong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2024
CB307: A Dual Targeting Costimulatory Humabody VH Therapeutic for Treating PSMA-Positive TumorsSophie Archer, Phillip M Brailey, Minjung Song, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2012
Optimization of an ether series of mGlu5 positive allosteric modulators: molecular determinants of MPEP-site interaction crossoverJason T Manka, Paige N Vinson, Karen J Gregory, et al.
Frontiers in Psychiatry|July 17, 2020
An Open Label Pilot Study of a Brief Psychosocial Intervention for Disaster and Trauma SurvivorsMeaghan Louise O'Donnell, Winnie Lau, Julia Fredrickson, et al.
Molecular Pharmacology|October 7, 2010
Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activityAlice L Rodriguez, Mark D Grier, Carrie K Jones, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 7, 2020
Transoral laser microsurgery and radiotherapy for oropharyngeal squamous cell carcinoma: Equitable survival and enhanced function compared with contemporary standards of careC Lucy Dalton, Kristijonas Milinis, David Houghton, et al.
Oncotarget|April 4, 2012
Stratification of Wilms tumor by genetic and epigenetic analysisRichard H Scott, Anne Murray, Linda Baskcomb, et al.
Nature Communications|February 7, 2026
Pan-RAF inhibitor exarafenib targets BRAF class II/III NSCLC and reveals ARAF-KSR1 resistance and combination strategiesTadashi Manabe, Hannah C Bergo, Qingtian Li, et al.
Plos One|December 20, 2012
Characterisation and validation of insertions and deletions in 173 patient exomesFrancesco Lescai, Silvia Bonfiglio, Chiara Bacchelli, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase InhibitorKevin W Gillman, John E Starrett, Michael F Parker, et al.
Pageof 34